Abbott Alinity s Anti-HCV II - HSA Registration DE0506690
Access comprehensive regulatory information for Abbott Alinity s Anti-HCV II in the Singapore medical device market through Pure Global AI's free database. This CLASS D IVD medical device is registered under HSA registration number DE0506690 and owned by Abbott GmbH. The device was registered on March 03, 2022.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The Alinity s Anti-HCV II assay is a chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of antibodies to hepatitis C virus (HCV) in human serum and plasma, including specimens collected postmortem (non-heart-beating), on the Alinity s System. The Alinity s Anti-HCV II assay is intended to be used as an aid in the diagnosis of HCV infection and as a screening test to prevent transmission of HCV to recipients of blood, blood components, cells, tissues, and organs.